The platelet count, serum AFP, CEA, tumor location, tumor differentiation, lymph node metastasis, chemotherapy, and TNM stage were all shown to be significant independent risk factors for CCA patients in a multivariate analysis. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.